東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Sunshine Act : = Analysis of Transfers of Value to Covered Entities.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Sunshine Act :/
Reminder of title:	Analysis of Transfers of Value to Covered Entities.
Author:	Stupca, Dan.
Description:	1 online resource (67 pages)
Notes:	Source: Masters Abstracts International, Volume: 83-12.
Contained By:	Masters Abstracts International83-12.
Subject:	Information technology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29252927click for full text (PQDT)
ISBN:	9798819378571

Sunshine Act : = Analysis of Transfers of Value to Covered Entities.
Stupca, Dan.

Sunshine Act :Analysis of Transfers of Value to Covered Entities. - 1 online resource (67 pages)

Source: Masters Abstracts International, Volume: 83-12.

Thesis (M.S.)--The College of St. Scholastica, 2022.

Includes bibliographical references

In 2013, the United States began tracking payments from health care companies to physicians in an attempt to remove potential influences on physicians to prescribe medications for financial incentives rather than therapeutic reasons. Additionally, several states have passed laws that place additional restrictions on the transactions between health care companies and physicians. This study analyzed the transactions that occurred between health care companies and physicians that were captured by the Sunshine Act against the volume of branded prescriptions written by the corresponding physician to patients on Medicare Part D insurance. The use of branded prescriptions to measure influence matches the approach taken by similar, previously published research (Brunt, 2019 & Pham-Kanter et al., 2013). Specific transfer types were isolated to determine if specific transactions are more likely to influence physicians than others. Current state laws were also analyzed to determine if any state laws that are effective at limiting influence should be recommended for nationwide expansion. Surprisingly, this study showed that there is no overarching, linear relationship between the value received by a physician and their prescribing habits of branded medications. Analysis of state laws showed that no particular type of law was effective in changing the volume of branded medications prescribed by individual physicians.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798819378571Subjects--Topical Terms:

532993
Information technology.
Subjects--Index Terms:

Data analysisIndex Terms--Genre/Form:

542853
Electronic books.

Sunshine Act : = Analysis of Transfers of Value to Covered Entities.
LDR:02837nmm a2200433K 4500 001 2355197
005 20230512095520.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798819378571
035 $a (MiAaPQ)AAI29252927
035 $a AAI29252927
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Stupca, Dan. $3 3695595
245 1 0 $a Sunshine Act : $b Analysis of Transfers of Value to Covered Entities.
264 0 $c 2022
300 $a 1 online resource (67 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 83-12.
500 $a Advisor: Olson, Brandon.
502 $a Thesis (M.S.)--The College of St. Scholastica, 2022.
504 $a Includes bibliographical references
520 $a In 2013, the United States began tracking payments from health care companies to physicians in an attempt to remove potential influences on physicians to prescribe medications for financial incentives rather than therapeutic reasons. Additionally, several states have passed laws that place additional restrictions on the transactions between health care companies and physicians. This study analyzed the transactions that occurred between health care companies and physicians that were captured by the Sunshine Act against the volume of branded prescriptions written by the corresponding physician to patients on Medicare Part D insurance. The use of branded prescriptions to measure influence matches the approach taken by similar, previously published research (Brunt, 2019 & Pham-Kanter et al., 2013). Specific transfer types were isolated to determine if specific transactions are more likely to influence physicians than others. Current state laws were also analyzed to determine if any state laws that are effective at limiting influence should be recommended for nationwide expansion. Surprisingly, this study showed that there is no overarching, linear relationship between the value received by a physician and their prescribing habits of branded medications. Analysis of state laws showed that no particular type of law was effective in changing the volume of branded medications prescribed by individual physicians.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Information technology. $3 532993
650 4 $a Ethics. $3 517264
650 4 $a Business administration. $3 3168311
650 4 $a Public health. $3 534748
650 4 $a Medical ethics. $3 526828
650 4 $a Pharmaceutical sciences. $3 3173021
653 $a Data analysis
653 $a Medicare Part D
653 $a Pharmaceutical spending
653 $a Physician payments
653 $a Sunshine Act
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0489
690 $a 0394
690 $a 0310
690 $a 0497
690 $a 0572
690 $a 0573
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a The College of St. Scholastica. $b Applied Data Analytics. $3 3689612
773 0 $t Masters Abstracts International $g 83-12.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29252927 $z click for full text (PQDT)